For research use only.
Storage
3 years,-20°C,powder
1 years,-80°C,in solvent
Description
CHD1Li 6.11, a potent oncogenic inhibitor and an orally bioavailable antitumor agent, shows the enzymatic inhibition of the with IC50 of 3.3 µM, and significantly reduces the tumor volume of colorectal cancer (CRC) xenografts generated from isolated quasi mesenchymal cells (M-Phenotype).